Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$247,591
+$247,591 QoQ
Shares Held
28,280
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#206
of 403 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Derivatives in IBRX
reported options exposure · as of Jun 30, 2026CallValue
$2,469,785
CallShares
282,100
PutValue
$3,349,663
PutShares
382,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names. IBRX ranks #51 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
438,746 | $30,997,404 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
159,256 | $21,138,048 | |
| 3 | ABVX |
Abivax S.A.
|
105,791 | $14,097,708 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
184,054 | $6,859,692 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
304,939 | $6,665,966 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
777,738 | $4,853,085 | |
| 7 | CYTK |
Cytokinetics Inc
|
54,889 | $4,675,993 | |
| 8 | RPRX |
Royalty Pharma plc
|
75,000 | $4,205,250 |
All Filings in IBRX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,469,785 | 282,100 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $3,349,663 | 382,600 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $247,591 | 28,280 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,833,298 | 369,400 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $2,245,009 | 292,700 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $152,693 | 77,118 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $536,725 | 218,181 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $648,914 | 245,801 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,489,387 | 827,039 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $128,844 | 50,330 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $350,684 | 94,270 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $256,990 | 40,663 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $108,474 | 20,200 | Call | Other | 2024-05-14 | |
| 2023-09-30 | $143,261 | 84,770 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $24,797 | 13,625 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||